仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Galiximab （IDEC 114） is a primatized immunoglobulin G1 （IgG1） lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized （cynomologous monkeys）, and the constant regions are human. Galiximab can be used in research of B-cell lymphoma